Literature DB >> 19333213

Changes in hepatitis C virus infection routes and genotype distribution in a Lithuanian cohort with chronic hepatitis C.

Valentina Liakina1, Danute Speiciene, Algimantas Irnius, Jonas Valantinas.   

Abstract

BACKGROUND: We evaluated the distribution of hepatitis C virus genotypes and determined their association with routes of infection according to the sex and age of the study subjects. MATERIAL/
METHODS: We studied 1158 patients with chronic hepatitis C. Hepatitis C virus antibodies were detected with a microparticle enzyme immunoassay, hepatitis C virus ribonucleic acid was identified via polymerase chain reaction, and hepatitis C virus genotypes were determined with a line probe assay. An anonymous questionnaire completed by all subjects included the date of chronic hepatitis C diagnosis, the age and sex of the patient, the hepatitis C virus genotype and subtype, and possible routes of infection.
RESULTS: Of the patients studied, 50.9% had more than 1 possible route of infection, 41.2% had a single route of infection, and 7.9% had an unknown route of infection. The most common hepatitis C transmission routes were intravenous drug use and tattoos in younger patients and surgery or long or multiple hospitalizations in older patients. The genotype distribution was as follows: genotype 1, 65.0% of patients; genotype 2, 26.3%; and genotype 3, 8.7%. The transmission of genotype 1 was associated primarily with surgery and that of genotype 3 was linked with intravenous drug use.
CONCLUSIONS: Today, the main routes of hepatitis C virus transmission are intravenous drug use and tattoos. Some hepatitis C infections are associated with surgery or are acquired from a family member. The shift in transmission pathways predetermined the shift in hepatitis C virus genotypes from 1 to 3.

Entities:  

Mesh:

Year:  2009        PMID: 19333213

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  5 in total

1.  Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme.

Authors:  Egle Ciupkeviciene; Janina Petkeviciene; Jolanta Sumskiene; Gediminas Dragunas; Saulius Dabravalskis; Edita Kreivenaite; Tadas Telksnys; Gediminas Urbonas; Limas Kupcinskas
Journal:  Viruses       Date:  2022-05-30       Impact factor: 5.818

2.  Anti-HCV prevalence in the general population of Lithuania.

Authors:  Valentina Liakina; Jonas Valantinas
Journal:  Med Sci Monit       Date:  2012-03

Review 3.  Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention.

Authors:  Lucas Wiessing; Marica Ferri; Bart Grady; Maria Kantzanou; Ida Sperle; Katelyn J Cullen; Angelos Hatzakis; Maria Prins; Peter Vickerman; Jeffrey V Lazarus; Vivian D Hope; Catharina Matheï
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

4.  Analysis of Transmission Routes of Hepatitis C Virus Based on Virus Genotyping in 341 Cases with Different Suspected Initial Infection Time Points in Hunan Province, China.

Authors:  Jian-Hua Lei; Jun Liang; Xing Gong; Xin-Qiang Xiao; Zi Chen; Feng Peng
Journal:  Med Sci Monit       Date:  2018-07-28

5.  Hepatitis C virus genotype 1 and 2 recombinant genomes and the phylogeographic history of the 2k/1b lineage.

Authors:  Reilly Hostager; Manon Ragonnet-Cronin; Ben Murrell; Charlotte Hedskog; Anu Osinusi; Simone Susser; Christoph Sarrazin; Evguenia Svarovskaia; Joel O Wertheim
Journal:  Virus Evol       Date:  2019-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.